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Linkage to chromosome 12p for familial Alzheimer disease (AD) has been inconsistent. Using 35 markers near the
centromere of chromosome 12, we investigated 79 Caribbean Hispanic families with AD. Two-point linkage analysis
using affected sib pairs yielded LOD scores of 3.15 at D12S1623 and 1.43 at D12S1042. The LOD score at
D12S1623 decreased to 1.62 in families with late-onset (age 165 years) AD (LOAD), but the LOD score at D12S1042
was unchanged. Among families negative for the apolipoprotein E (APOE-e4) allele, the LOD score for D12S1623
was lower (1.01), whereas that for D12S1042 increased to 1.73. Among families positive for the APOE-e4 allele,
none of the LOD scores reached 1. Multipoint affected-relative-pair analysis showed peaks at D12S1623 (non-
parametric linkage [NPL] score 1.52; ) and near D12S1042, at D12S1057 (NPL score 1.57; ).Pp .028 Pp .027
NPL scores for both D12S1623 and D12S1057 increased in families affected with LOAD, but, in APOE-e4–negative
families, only scores for the region flanking D12S1623 remained elevated (NPL score 1.74; ). This studyPp .013
of Caribbean Hispanics with familial AD extends and provides modest evidence of linkage to loci on chromosome
12p. Linkage varied by age at onset of AD and by the presence or absence of the APOE-e4 allele.
A putative gene on chromosome 12 (AD5 [MIM
602096]), conferring susceptibility to late-onset Alzhei-
mer disease (LOAD [MIM 104300]), was identified by
Pericak-Vance et al. (1997). Subsequent confirmation has
been inconsistent and contradictory (Pericak-Vance et al.
1997; Rogaeva et al. 1998; Wu et al. 1998; Scott et al.
1999, 2000). Rogaeva et al. (1998) observed locus het-
erogeneity attributed to the presence of APOE-e4. Scott
et al. (2000) found stronger linkage in the absence of
apolipoprotein E (APOE-e4 [MIM 107741]) and when
Lewy bodies (Lewy-body dementia [MIM 127750]) were
detected at autopsy in at least one affected familymember.
Compared with other ethnic groups, Caribbean His-
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panics have an increased frequency of AD (Gurland et
al. 1999; Tang et al. 2001), as do Mexican Americans
(Perkins et al. 1997). The current study was designed to
extend and confirm the evidence of linkage, on chro-
mosome 12, to AD in Caribbean Hispanics. Patients
were identified in the Alzheimer’s Disease Research Cen-
ter at Columbia University, in an epidemiological study
in northern Manhattan, and in clinics in Dominican Re-
public and Puerto Rico. The Institutional Review Board
of Columbia PresbyterianMedical Center and Columbia
University Health Sciences and the Bioethics National
Committee for Research in the Dominican Republic ap-
proved the study. Informed consent was obtained either
from the participant or, when the individual was de-
mented, from a family member.
Patients with AD met criteria set by the National In-
stitute ofNeurological andCommunicativeDisorders and
Stroke and the Alzheimer’s Disease and RelatedDisorders
Association (NINCDS-ADRDA) (McKhann et al. 1984).
The Clinical Dementia Rating Scale (CDR) (Hughes et al.
1982) was used to rate disease severity. Brain imaging and
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Table 1
Description of Caribbean Hispanic Families
Characteristic Data
Number of families 79




















a Individuals with unknown affection status were not
included.
other laboratory studies were reviewed and offered when
medically required for diagnosis. The neuropsychological
tests used included a battery developed and evaluated for
use in Hispanic individuals (Pittman et al. 1992; Stern et
al. 1992).
Only individuals meeting criteria for probableAD,with
a CDR1.0, were classified as case subjects for analyses.
Individuals with other forms of dementia, mild AD (CDR
0.5), and possible AD were classified as having unknown
status. Age at onset was based on family report. Blood
was obtained from all patients, living siblings, and other
family members, when possible. Genotyping of APOE
was performed using standard methods (Hixson and Ver-
nier 1990; Maestre et al. 1995).
Multiplex PCR, up to four products per reaction, was
performed using 50 ng of DNA in a 10-ml reaction that
contained 10 mM Tris-HCl pH 8.3 at 25C, 50 mM
KCl, 1.6–2.0 mM MgCl2, 0.25 mM of each dNTP, var-
iable amounts of each PCR primer to produce even peak
heights, and 0.1 units of Platinum Taq DNA Polymerase
(Life Technologies), by touchdown PCR (Don et al.
1991) in 384-well plates in MJ Research thermocyclers.
The annealing temperature was decreased 2C per cycle,
from 65C to 55C (94C denaturing), and then 32 ad-
ditional cycles of 90C denaturing, 55C annealing, and
72C elongation were performed. Amplification prod-
ucts were pooled using a TECAN Genesis robot, Ta-
mara-labeled size standard was added (ABI 400HD),
and the mixture was resolved using POP4 polymer on
a 36-cM capillary array and was detected by an ABI
3100 DNA sequencer. Then the data were analyzed by
GENESCAN 3.7 and GENOTYPER 3.0 (Applied Bio-
Systems). Two readers, shielded from clinical diagnoses,
independently interpreted genotypes.
Nonpaternity was examined using PEDCHECK
(O’Connell and Weeks 1998) and RELATIVE (Goring
and Ott 1997), prior to linkage analysis. We excluded
individuals from the analysis when the theoretical max-
imum IBD sharing was estimated to be !50%. Families
were considered to be APOE-e4 positive if 75% of the
affected individuals had at least one e4-allele, and all
other families were considered to be APOE-e4 negative
(Rogaeva et al. 1998). Families with ADwere considered
to be affected with LOAD if 75% of the affected indi-
viduals reported onset at age 165 years.
We mapped the region extending from 12pter to
12q21.13, using 35 microsatellite markers. Initially, a
two-point sib-pair analysis was conducted using AN-
ALYZE (Goring and Terwilliger 2000). The nonpara-
metric model applies the pseudomarker allele-sharing
method, under the assumptions that parents are heter-
ozygotes and that the mode of inheritance is autosomal
recessive (Knapp et al. 1994). Allele frequencies were
based on data derived from all participating familymem-
bers. Multipoint nonparametric linkage analysis was im-
plemented in GENEHUNTER 2 (Kruglyak et al. 1996).
When necessary, noninformative nonfounders (e.g., un-
affected children) were excluded, to circumvent the com-
putational limitations of the software. Maps from the
Marshfield Medical Research Foundation and the Ge-
nome Database were used for locus order and inter-
marker distance. The sibling transmission/disequilib-
rium test (Sib-TDT) was used to test allelic association
and was expressed as a Z score, with the computed P
values based on the normal distribution approximation
(Spielman and Ewens 1998).
In the 79 families investigated, therewere 320 relatives
(table 1). The mean age of living participants was 73.3
years, and the mean age at onset for affected individuals
was 74.1 years. The majority of the families (67
[84.8%]) were from the Dominican Republic, 9 (11.4%)
were from Puerto Rico, and 3 (3.8%) came from else-
where in the Caribbean. Twenty-five families have three
or more affected members. The majority of families had
two affected members.
There were 15 individuals from these families for
whom DNA was not available; thus, only 384 individ-
uals (including probands and relatives) were included in
the linkage and association analyses. Fifty-one percent
of the members of the families met criteria for probable
AD, 38% were unaffected, and 11% were coded as un-
known, either because they (a) had milder dementia
(CDR 0.5), possible AD, or another cause of dementia
or (b) were !40 years of age (table 1). Unaffected in-
dividuals were defined as those without dementia at an
age comparable to that of the probands (table 1).
Reports 239
Figure 1 Results of the two-point analysis showing linkage for markers D12S1623 (LOD 3.15) and D12S1042 (LOD1.43) on chromosome
12. The two markers are ∼30 cM apart. The upper graph shows the results overall and when restricted by age at onset 165 years. The lower
graph shows the results stratified by the presence or absence of an APOE-e4 allele.
The frequency of APOE-e4 among affected individuals
was significantly higher than expected under the null
hypothesis of no association ( ;Zp 4.79 Pp 8.3#
). On the basis of our classification, 32 families were710
APOE-e4 positive and 47 families were APOE-e4 neg-
ative; 8 families had predominantly early-onset disease,
and 71 families had LOAD.
The two-point analysis showed the strongest evidence
for linkage for markers D12S1623 (LOD 3.15) and
D12S1042 (LOD 1.43), ∼30 cM apart (fig. 1). D12S1623
is located ∼4 cM telomeric of alpha-2-macroglobulin
(A2M [MIM 103950]), but analysis of A2M showed no
evidence for linkage (LOD 0.75). When the analysis was
restricted to families affected with LOAD, the D12S1623
LOD score decreased to 1.63, whereas that forD12S1042
did not change. Among APOE-e4–negative families, the
LOD score for D12S1623 decreased further, to 1.01, but
the LOD for D12S1042 increased to 1.73. The LOD
scores for D12S1057 and D12S398, near D12S1042, also
were 11. None of the LOD scores reached 1.0 in the
APOE-e4–positive families.
Multipoint affected-relative-pair analysis showed
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Figure 2 Results of multipoint affected-relative-pair analyses, showing peaks near the same two markers, D12S1623 (NPL score 1.52;
) and D12S1057 (NPL score 1.57; ). Among late-onset families, the NPL score for D12S1623 was 2.01 ( ), whereasPp .028 Pp .027 Pp .006
that for D12S1057 was 1.63 ( ). The upper graph shows the results overall and when restricted by age at onset 165 years. The lowerPp .021
graph shows the results stratified by the presence or absence of an APOE-e4 allele.
peaks at D12S1623 (NPL score 1.52; ) andPp .028
near D12S1042 and D12S1057 (NPL score 1.57; Pp
) (fig. 2). In families affected with LOAD, the NPL.027
score for D12S1623 was 2.01 ( ), whereas thatPp .006
for D12S1057 was 1.63 ( ). Among APOE-Pp .021
e4–negative families, scores for the region flanking
D12S1623 remained elevated (NPL score 1.74; Pp
), but, among APOE-e4–positive families, there was.013
no evidence of linkage for the region flanking D12S1623
(NPL score 0.25; ). The NPL score for thePp .379
D12S1042 region remained unchanged (NPL score 1.34;
) regardless of APOE-e4 status.Pp .053
The Sib-TDT was used to test for linkage in the pres-
ence of association flanking the markers D12S1623 and
D12S1042. Allele 5 of D12S374, near the first peak
(1.46 cM from D12S1623), was associated with LOAD
( ; ). Allele 10 of D12S1090, 7.68Zp 2.27 Pp .0116
cM from D12S1042, showed the strongest evidence for
linkage ( ; ). The strength of asso-Zp 2.93 Pp .0017
ciation varied with age at onset and with the presence
or absence of the APOE-e4 allele, for several markers
(table 2).
The main findings of this study are consistent with the
linkage of LOAD to chromosome 12p in Caribbean His-
panics. Linkage was stronger in APOE-e4–negative fam-
ilies. Despite our previous findings of a weak association
(Romas et al. 2000), there was no evidence of linkage to
A2M in a larger set of families. The strongest support for
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Table 2










Z P Z P Z P Z P
D12S1694 10 1.68 .0465
D12S374 5 1.80 .0359 2.27 .0116 1.80 .0359
D12S2209 12 1.72 .0427
D12S89 12 1.65 .0495
D12S1682 6 2.07 .0192
D12S1042 4 2.02 .0217 2.27 .0116
D12S1090 10 2.93 .0017 2.93 .0017 1.84 .0329 1.86 .0314
D12S1701 4 1.77 .0384
D12S339 8 1.65 .0495
D12S390 6 2.32 .0101 2.01 .0222 2.12 .0170
NOTE.—Only the alleles with one-sided P value (unadjusted) of .05 are listed.
linkage in these Caribbean Hispanic families was on 12p,
telomeric to the sites with highest LOD scores reported
by others (Rogaeva et al. 1998;Wu et al. 1998). However,
we also obtained modest support for linkage at a second
site—corresponding to D12S1057 and D12S1042, closer
to the centromere—first reported by Scott et al. (1999,
2000).
Prior studies of chromosome 12 have been primarily
in non-Hispanic whites of American or European origin
(Pericak-Vance et al. 1997; Blacker et al. 1998; Rogaeva
et al. 1998; Scott et al. 1999, 2000). Attempts to fine-
map this candidate region of chromosome 12 have met
with mixed success (Clatworthy et al. 1997; Blacker et
al. 1998; Wu et al. 1998; Scott et al. 1999, 2000; Zu-
benko et al. 1999; Dodel et al. 2000). Wu et al. (1998)
could not confirm linkage, and Rogaeva et al. (1998)
found evidence of linkage to an adjacent region. Scott
et al. (1999, 2000) showed that linkage was conditional
on the presence or absence of APOE-e4 and on the find-
ing of Lewy bodies in post mortem material from family
members. Our results among Caribbean Hispanics also
provide support for two sites potentially linked to AD.
These may be (a) two independent peaks, ∼30 cM away
from each other, possibly representing two separate
genes, (b) a single gene with chance variation, or (c) two
false-positive peaks. A number of independent investi-
gations using different populations and different analytic
approaches show modest peaks on 12p (albeit not at
exactly the same location). Although the likelihood of
a false-positive peak on 12p is reduced, it is not
eliminated.
In the two-point analysis, support for linkage at
D12S1623 was substantially higher than that for the
multipoint affected-relative-pair analysis. The polymor-
phism information content for D12S1623 was low
(0.42). When the information content improved in the
multipoint analysis, the support for linkage may have
declined because of truly weaker linkage. However, in
this type of analysis, errors in tightly linked regions can
be exaggerated, reducing the evidence favoring linkage
(Risch and Giuffra 1992).
These regions on chromosome 12 contains two inter-
esting genes: that for A2M and that for the low-density
lipoprotein receptor–related protein (LRP1 [MIM
107770]) (Blacker et al. 1998; Liao et al. 1998). With
some exceptions, neither association has been confirmed
in subsequent studies (Clatworthy et al. 1997; Baum et
al. 1998; Hollenbach et al. 1998; Beffert et al. 1999;
Dodel et al. 2000; Gibson et al. 2000; Romas et al.
2000).
The strengths of our study are the unique population
and the criterion-based, conservative diagnoses. Al-
though we have had only three autopsies to date, all
have confirmed clinical diagnoses of probable AD. The
difficulty encountered in refining the candidate region
on chromosome 12 has been attributed to clinical and
locus heterogeneity. The exact location has not been rep-
licated in any study, but the identification of families
from different ethnic backgrounds who exhibit linkage
to approximately the same region of 12p strengthens the
possibility that a susceptibility gene may exist on this
chromosome.
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